These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 23900351)

  • 1. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
    Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
    Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer.
    Luo Q; Wei C; Li X; Li J; Chen L; Huang Y; Song H; Li D; Fang L
    Oncol Rep; 2014 Mar; 31(3):1096-102. PubMed ID: 24402230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.
    Zhang J; Kong X; Li J; Luo Q; Li X; Shen L; Chen L; Fang L
    Oncol Rep; 2014 Mar; 31(3):1357-63. PubMed ID: 24366472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-7 arrests cell cycle in G1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells.
    Zhang X; Hu S; Zhang X; Wang L; Zhang X; Yan B; Zhao J; Yang A; Zhang R
    Biochem Biophys Res Commun; 2014 Jan; 443(3):1078-84. PubMed ID: 24370822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer.
    Li D; Jian W; Wei C; Song H; Gu Y; Luo Y; Fang L
    Int J Clin Exp Pathol; 2014; 7(11):7672-80. PubMed ID: 25550803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.
    Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai LS; Zhang L; Hu Y
    Carcinogenesis; 2013 Feb; 34(2):426-35. PubMed ID: 23104180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-107 induces cell cycle arrests by directly targeting cyclin E1 in ovarian cancer.
    Tang Z; Fang Y; Du R
    Biochem Biophys Res Commun; 2019 Apr; 512(2):331-337. PubMed ID: 30885433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA-15a mediates cell cycle arrest and potentiates apoptosis in breast cancer cells by targeting synuclein-γ.
    Li P; Xie XB; Chen Q; Pang GL; Luo W; Tu JC; Zheng F; Liu SM; Han L; Zhang JK; Luo XY; Zhou X
    Asian Pac J Cancer Prev; 2014; 15(16):6949-54. PubMed ID: 25169552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
    Li G; Chong T; Xiang X; Yang J; Li H
    Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
    Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
    Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
    Cui W; Zhang S; Shan C; Zhou L; Zhou Z
    FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2.
    Zhou J; Tian Y; Li J; Lu B; Sun M; Zou Y; Kong R; Luo Y; Shi Y; Wang K; Ji G
    Biochem Biophys Res Commun; 2013 Apr; 433(2):207-12. PubMed ID: 23466356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [miR-497 suppresses proliferation of human cervical carcinoma HeLa cells by targeting cyclin E1].
    Han J; Huo M; Mu M; Liu J; Zhang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):597-600. PubMed ID: 24909281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
    Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
    Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-15/16 complex targets p70S6 kinase 1 and controls cell proliferation in MDA-MB-231 breast cancer cells.
    Janaki Ramaiah M; Lavanya A; Honarpisheh M; Zarea M; Bhadra U; Bhadra MP
    Gene; 2014 Dec; 552(2):255-64. PubMed ID: 25261849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma.
    Cai CK; Zhao GY; Tian LY; Liu L; Yan K; Ma YL; Ji ZW; Li XX; Han K; Gao J; Qiu XC; Fan QY; Yang TT; Ma BA
    Oncol Rep; 2012 Nov; 28(5):1764-70. PubMed ID: 22922827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-15a/miR-16 induces mitochondrial dependent apoptosis in breast cancer cells by suppressing oncogene BMI1.
    Patel N; Garikapati KR; Ramaiah MJ; Polavarapu KK; Bhadra U; Bhadra MP
    Life Sci; 2016 Nov; 164():60-70. PubMed ID: 27596816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell proliferation, invasion and migration by targeting Sox5.
    Renjie W; Haiqian L
    Cancer Lett; 2015 Jan; 356(2 Pt B):568-78. PubMed ID: 25305447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The miR-15 family enhances the radiosensitivity of breast cancer cells by targeting G2 checkpoints.
    Mei Z; Su T; Ye J; Yang C; Zhang S; Xie C
    Radiat Res; 2015 Feb; 183(2):196-207. PubMed ID: 25594541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.